Government disburses ₹35,354 crore under PLI schemes till March 2026

SENSEX 73,514.35

 -338.55

NIFTY 22,738.45

 -150.50

CRUDEOIL 9,443.00

+ 132.00

GOLD 145,810.00

 -709.00

SILVER 208,955.00

 -2,530.00

SENSEX 73,514.35

 -338.55

NIFTY 22,738.45

 -150.50

NIFTY 22,738.45

 -150.50

CRUDEOIL 9,443.00

+ 132.00

CRUDEOIL 9,443.00

+ 132.00

GOLD 145,810.00

 -709.00

'; } document.getElementById("lgdv").innerHTML = htmlElements; } function numberformat(i) { return Number(parseFloat(i).toFixed(2)).toLocaleString('en', { minimumFractionDigits: 2 }) } async function gatherResponse(response) { const { headers } = response; const contentType = headers.get('content-type') || ''; if (contentType.includes('application/json')) { return await response.json() } return response.text(); } function getWidth() { if (Math.max(document.body.scrollWidth,document.documentElement.scrollWidth,document.body.offsetWidth,document.documentElement.offsetWidth,document.documentElement.clientWidth) > 991) { document.getElementById("mob").style.display = "none"; document.getElementById("lgdv").style.display = "block"; } else { document.getElementById("mob").style.display = "block"; document.getElementById("lgdv").style.display = "none"; } } getWidth(); THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.

The pharmaceuticals sector recorded cumulative sales of over ₹3.64 lakh crore under the PLI scheme, enabling the domestic manufacture of 1,931 products, including 191 bulk drugs produced in India for the first time

By PTI

Updated - July 24, 2026 at 04:51 PM. | New Delhi

Jitin Prasada, Minister of State for Commerce and Industry | Photo Credit: ANI

The government has disbursed Rs 35,354 crore to beneficiaries of the Production Linked Incentive (PLI) schemes as on March 31 this year, Parliament was informed in the Rajya Sabha on Friday.

The government has launched the PLI schemes in 2020 for 14 key sectors with an approved outlay of Rs 1.91 lakh crore to enhance India's manufacturing capabilities, attract investments, promote exports, generate employment and reduce import dependence.

In a written reply to the Rajya Sabha, Minister of State for Commerce and Industry Jitin Prasada said as "on March 31, 2026, under the PLI schemes, 892 applications have been approved across 14 sectors, resulting in actual investment of over Rs 2.40 lakh crore, production/sales of over Rs 22.66 lakh crore, exports of over Rs 15.2 lakh crore, employment generation of over 14.15 lakh (direct and indirect) out of which 8.4 lakhs is Direct employment and cumulative incentive disbursement of Rs 35,354 crore".

He said that the pharmaceuticals sector has recorded cumulative sales of over Rs 3.64 lakh crore under the scheme.

It has also enabled the domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs manufactured in India for the first time, thereby strengthening domestic manufacturing capabilities, he added.

Published on July 24, 2026

THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS. THIS AD SUPPORTS OUR JOURNALISM. SUBSCRIBE FOR MINIMAL ADS.Sign into Unlock benefits!

• Access 10 free stories per month
• Get notified by email for early preview to new features, discounts & offers